598 related articles for article (PubMed ID: 29967761)
1. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.
Hahne JC; Valeri N
Front Oncol; 2018; 8():226. PubMed ID: 29967761
[TBL] [Abstract][Full Text] [Related]
2. Interplay among SNAIL Transcription Factor, MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Regulation of Tumor Growth and Metastasis.
Skrzypek K; Majka M
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947678
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells.
Heery R; Finn SP; Cuffe S; Gray SG
Cancers (Basel); 2017 Apr; 9(4):. PubMed ID: 28430163
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNAs as Potential Regulators of EMT-Related Transcription Factors in Colorectal Cancer-A Systematic Review and Bioinformatics Analysis.
Pavlič A; Hauptman N; Boštjančič E; Zidar N
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565409
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications.
Khanbabaei H; Ebrahimi S; García-Rodríguez JL; Ghasemi Z; Pourghadamyari H; Mohammadi M; Kristensen LS
J Exp Clin Cancer Res; 2022 Sep; 41(1):278. PubMed ID: 36114510
[TBL] [Abstract][Full Text] [Related]
8. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract][Full Text] [Related]
9. LncRNAs Roles in Chemoresistance of Cancer Cells.
Taghvimi S; Abbaszadeh S; Banan FB; Fard ES; Jamali Z; Najafabadi MA; Savardashtaki A; Movahedpour A
Curr Mol Med; 2022; 22(8):691-702. PubMed ID: 34711162
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
[TBL] [Abstract][Full Text] [Related]
11. Non-coding RNAs as Novel Biomarkers in Cancer Drug Resistance.
Yang H; Qi C; Li B; Cheng L
Curr Med Chem; 2022; 29(5):837-848. PubMed ID: 34348605
[TBL] [Abstract][Full Text] [Related]
12. The functional role of long noncoding RNA in resistance to anticancer treatment.
Qu Y; Tan HY; Chan YT; Jiang H; Wang N; Wang D
Ther Adv Med Oncol; 2020; 12():1758835920927850. PubMed ID: 32536982
[TBL] [Abstract][Full Text] [Related]
13. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
Zhang X; Yang H
Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
[TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and Cancer Drug Resistance.
Gomes BC; Rueff J; Rodrigues AS
Methods Mol Biol; 2016; 1395():137-62. PubMed ID: 26910073
[TBL] [Abstract][Full Text] [Related]
15. Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer.
Zhang HB; Hu Y; Deng JL; Fang GY; Zeng Y
Front Pharmacol; 2023; 14():1243934. PubMed ID: 37781691
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance.
Hashemi M; Hajimazdarany S; Mohan CD; Mohammadi M; Rezaei S; Olyaee Y; Goldoost Y; Ghorbani A; Mirmazloomi SR; Gholinia N; Kakavand A; Salimimoghadam S; Ertas YN; Rangappa KS; Taheriazam A; Entezari M
Pharmacol Res; 2022 Dec; 186():106535. PubMed ID: 36334877
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
Hashemi M; Hasani S; Hajimazdarany S; Mirmazloomi SR; Makvandy S; Zabihi A; Goldoost Y; Gholinia N; Kakavand A; Tavakolpournegari A; Salimimoghadam S; Nabavi N; Zarrabi A; Taheriazam A; Entezari M; Hushmandi K
Int J Biol Macromol; 2022 Dec; 222(Pt A):1151-1167. PubMed ID: 36191781
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.
Guo F; Parker Kerrigan BC; Yang D; Hu L; Shmulevich I; Sood AK; Xue F; Zhang W
J Hematol Oncol; 2014 Mar; 7():19. PubMed ID: 24598126
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNA and Drug resistance in cholangiocarcinoma.
Wu Z; Jiang S; Chen Y
Noncoding RNA Res; 2024 Mar; 9(1):194-202. PubMed ID: 38125756
[TBL] [Abstract][Full Text] [Related]
20. The role of non-coding RNAs in chemotherapy for gastrointestinal cancers.
Dashti F; Mirazimi SMA; Rabiei N; Fathazam R; Rabiei N; Piroozmand H; Vosough M; Rahimian N; Hamblin MR; Mirzaei H
Mol Ther Nucleic Acids; 2021 Dec; 26():892-926. PubMed ID: 34760336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
